Faulkner Amanda L, Swanson Eric, McLarney Thomas L, Lee Cortney Y, Rebel Annette
From the Departments of Anesthesiology.
Surgery, University of Kentucky, Lexington, Kentucky.
A A Pract. 2019 Mar 1;12(5):136-140. doi: 10.1213/XAA.0000000000000861.
Dexmedetomidine is a selective α2-agonist, frequently used in perioperative medicine as anesthesia adjunct. The medication carries a Food and Drug Administration pregnancy category C designation and is therefore rarely used for parturients undergoing nonobstetric surgery. We are reporting the use of dexmedetomidine in the anesthetic management of a parturient undergoing minimally invasive unilateral adrenalectomy for pheochromocytoma during the second trimester of pregnancy. Additionally, because of the multiple endocrine neoplasia type 2A constellation with diagnosis of medullary thyroid cancer, the patient underwent a total thyroidectomy 1 week after the adrenalectomy.
右美托咪定是一种选择性α2受体激动剂，常用于围手术期医学作为麻醉辅助药物。该药物被美国食品药品监督管理局列为C类妊娠用药，因此很少用于接受非产科手术的产妇。我们报告了右美托咪定在一名妊娠中期因嗜铬细胞瘤接受微创单侧肾上腺切除术的产妇麻醉管理中的应用。此外，由于患者患有2A型多发性内分泌腺瘤病并诊断为甲状腺髓样癌，在肾上腺切除术后1周接受了甲状腺全切术。
